These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Lens M; Bataille V Cancer Causes Control; 2008 Jun; 19(5):437-42. PubMed ID: 18197460 [TBL] [Abstract][Full Text] [Related]
25. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
26. [Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s]. Magnusson C; Reeves G Lakartidningen; 2005 Apr 18-24; 102(16):1228-30. PubMed ID: 15921095 [No Abstract] [Full Text] [Related]
28. [Hormone replacement therapy in patients after breast cancer]. Köninger A; Kümmel S; Kimmig R MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144 [No Abstract] [Full Text] [Related]
29. Update: the latest on hormone replacement therapy. Packin GS J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456 [TBL] [Abstract][Full Text] [Related]
30. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis]. Brettes JP; Mathelin C Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474 [No Abstract] [Full Text] [Related]
32. [New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use]. Lakartidningen; 2002 Jul; 99(28-29):3031-4. PubMed ID: 12170514 [TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy and malignant melanoma: to prescribe or not to prescribe? Durvasula R; Ahmed SM; Vashisht A; Studd JW Climacteric; 2002 Jun; 5(2):197-200. PubMed ID: 12051116 [TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy and ovarian cancer risk--any news? Riman T Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640 [No Abstract] [Full Text] [Related]
35. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?]. Mathelin C; Brettes JP Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563 [No Abstract] [Full Text] [Related]
36. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale. Berg AO; Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162 [No Abstract] [Full Text] [Related]
37. [Hormone replacement therapy and vessels: what's the story in 2007?]. Chabbert-Buffet N J Mal Vasc; 2007 Dec; 32(4-5):190-1. PubMed ID: 17698308 [No Abstract] [Full Text] [Related]
38. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713 [TBL] [Abstract][Full Text] [Related]
40. [Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully]. Odlind V Lakartidningen; 2005 Apr 18-24; 102(16):1217-8. PubMed ID: 15921094 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]